3811 results for «2025年7月12日到2025年8月16日+天数»

Filter By

3811 results

Wow! I’m going to be on the #GulfPCR Programme

Having my submission accepted by GulfPCR-GIM means so much! Discover this two-days Course to see why it’s such huge news for me and my career!

Celebrating 20 years of EuroIntervention!

22 May 2025

According to Editor-in-Chief, Davide Capodanno, EuroIntervention marks this milestone by continuing its upward trajectory, blending cutting-edge and traditional elements to bring the latest data to its readers faster than ever before.

Author

Davide Capodanno
Celebrating 20 years of EuroIntervention!

Become an Industry Partner at PCR Imaging Valves Madrid

Discover the many ways in which to boost your brand’s visibility before, during and after the Workshop!

What is EuroPCR?

Get a glimpse of the huge scope, key features and a brief history of the outstanding World-Leading Course in #interventionalcardiology - and why to be in Paris on 19-22 May 2026!
What is EuroPCR?

EuroIntervention: your academic reference journal for coronary, valvular and structural interventions

07 Feb 2024

EuroIntervention Journal is an international, English language, peer-reviewed journal which publishes high quality academic research in coronary, valvular, structural and surgical cardiovascular interventions.

EuroIntervention: Your reference journal for coronary, valvular and structural interventions

The PCR Textbook

08 Jul 2025

The PCR Textbook covers the length and breadth of percutaneous cardiovascular interventional practice, in particular diagnostic and therapeutic areas.

The PCR Textbook in percutaneous cardiovascular interventional practice

PCR Seminars overview

Jan-Dec 2025

Find out what are PCR Seminars, gain an overview of the topics and the target audience.

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

Positive 3-year results from FIRE Trial demonstrate Supraflex Cruz’s safety and efficacy in elderly heart attack patients

26 Sep 2025

The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma

01 Apr 2025

Mirvat Alasnag provides her take on the Lancet Commission for atherosclerosis published during the ACC.25 in Chicago.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma

Pi-Cardia’s ShortCut™ Becomes First Leaflet Modification Technology to Receive CMS NTAP for Valve-in-Valve TAVR

06 Aug 2025

Maximise Your Brand's Impact in Paris

Don’t miss the chance to elevate your brand's profile at EuroPCR 2026. From sponsored sessions and training workshops to extensive exhibition spaces, explore how you can engage with a global audience and support key Course initiatives.

PCR Seminars 2024: education brought to your doorstep!

Jupiter Endovascular closes oversubscribed Series B Financing, surpassing $40 million target

07 Oct 2025

Foldax announces positive one-year data on TRIA Mitral Valve

27 Jun 2025

Bentley acquired the GoBack catheter

13 Sep 2022

Quadruple pulmonary vein stenting for post-ablation stenosis

28 Apr 2025

Watch this EuroIntervention image to discover how a complex case of severe pulmonary vein stenosis after atrial fibrillation ablation was successfully managed with multi-stent implantation and intravascular imaging guidance — restoring the patient’s quality of life almost immediately.

Quadruple pulmonary vein stenting for post-ablation stenosis

Elixir Medical announces launch of LithiX™ Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Europe

09 Apr 2025

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Yohei Ohno

Author

Yohei Ohno
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

SMT Announces Completion of Patient Enrolment for TUXEDO-2 Trial

16 Aug 2024

Didn’t find what you were looking for?